Picture Fairtec GmbH Worldwide Event Solutions 600x60px
Document › Details

Biocartis Group N.V.. (4/21/17). "Press Release: Disclosure of a Transparency Notification (Article 14, paragraph 1 of the Belgian Act of 2 May 2007 on disclosure of major shareholdings)". Mechelen.

Organisations Organisation Biocartis Group N.V. (Euronext Brussels: BCART)
  Group Biocartis (Group)
  Organisation 2 Sycomore Asset Management (FR)
Products Product Idylla™ molecular diagnostics system
  Product 2 finance
Index term Index term Biocartis–Sycomore Asset Management: investment, 201704 acquisition of shares resulting in 5.15% holding of voting rights in Biocartis

Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative molecular diagnostics company (Euronext Brussels: BCART), announces today in accordance with Article 14, paragraph 1 of the Belgian Act of 2 May 2007 on the disclosure of major shareholdings in issuers whose shares are admitted to trading on a regulated market (the ‘Belgian Transparency Act’), that it received a transparency notification dated 19 April 2017 (the ‘Notification’), indicating that as a result of the acquisition of voting securities on 19 April 2017, Sycomore Asset Management now holds 5.15% of the voting rights in Biocartis. As a result, it has crossed the notification threshold of 5%.

The Notification contains the following information:

> Reason for the Notification: acquisition or disposal of voting securities or voting rights.
> Notification by: a person that notifies alone.
> Persons subject to the notification requirement: Sycomore Asset Management, 14 avenue Hoche, 75 008 Paris, France.
> Transaction date: 19 April 2017.
> Threshold that is crossed: 5%.
> Denominator: 44,648,105.
> Details of the Notification: Sycomore Asset Management holds 2,301,126 voting securities.
> Additional information: Sycomore Asset Management holds the participation solely in the framework of its activities as management company of UCI and UCITS and discretionary mandates.

The Notification is available here on the website of the Company.

Pursuant to the Belgian Transparency Act and the articles of association of the Company, a notification to the Company and the Belgian Financial Services and Markets Authority (‘FSMA’) is required by all natural and legal persons in each case where the percentage of voting rights in the Company held by such persons reaches, exceeds or falls below the threshold of 3%, 5%, 10%, and every subsequent multiple of 5%, of the total number of voting rights in the Company.

Record changed: 2017-04-30


Picture [LSUS] – The Business Web Portal 600x60px

More documents for Biocartis (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px

» top